FDA Clearance Tracker · P990040-S034
TRUFILL n-BCA Liquid Embolic System (LES), TRUFILL n-BCA Liquid Embolic System Procedural Set
Last checked: Nov 20, 2026Latest source record: Dec 16, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 16, 2025
Approved
Time to decision
316 days
Received Feb 3, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P990040-S034
- Device name
- TRUFILL n-BCA Liquid Embolic System (LES), TRUFILL n-BCA Liquid Embolic System Procedural Set
- Applicant
- Cerenovus, Inc.
- Applicant location
- Miami, FL
- Received
- Feb 3, 2025
- Decided
- Dec 16, 2025
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P990040
Device type
- Device type
- Neurovascular Liquid Embolic Agent (SGU)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
The TRUFILL n-BCA Liquid Embolic System is indicated for the embolization of cerebral arteriovenous malformations (AVMs) when pre-surgical devascularization is desired and for embolization of the Middle Meningeal Artery (MMA) for the treatment of symptomatic subacute and chronic Subdural Hematoma (SDH) as an adjunct to surgery.
Source documents
Other decisions for Cerenovus, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262419 · Decided Aug 14, 2026 · 30 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
K262398 · Decided Aug 13, 2026 · 30 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
K251828 · Decided Aug 22, 2025 · 70 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.